Background: Protamine, an immunologically active, cationic amine, has been suspected of impairing lung mechanics when administered after cardiopulmonary bypass (CPB) to reverse heparin. Whether such adverse changes are an effect of protamine itself, the forma tion of heparin-protamine complexes, the extent of heparin anticoagulation, or its chemical reversal is not known.
Methods and Results: Using a computer-controlled, forced-ventilation method over a vari ety of physiological tidal volume (VT) and frequency (f) combinations, we prospectively studied 18 adult, elective patients before systemic heparinization and after protamine rever sal to confirm and, possibly, elucidate an etiology for any adverse pulmonary effects. Prot amine and heparin doses, their sum (Σ-dose) and differential (Δ-dose) doses, and activated clotting times were tabulated. In all patients, lung resistance (RL) and, to a lesser extent, elastance (EL) increased after CPB, compared with pre-CPB values (P < .05). However, RL particularly increased after CPB with increases correlated to the Δ-dose, where RL PRE-POST = -0.037 [Δ-dose] - 0.56f - 0.019VT + 36.1 (r = .652, P < .05). No other significant correla tions were found among the remaining clinical parameters and changes in either RL or E L, or any chest wall component (all P > .05).
Conclusions: The changes seen in RL after CPB were greatest in those patients receiving the most nearly balanced doses of heparin and protamine, and were not related significantly to the total heparin or protamine doses, or their sum. This suggests that the extent of antico agulation reversal or formation of heparin-protamine complexes, and not protamine itself, are more responsible for changes seen in lung mechanics. The changes seen were limited solely to RL, and not in either EL nor the chest wall mechanical properties.
Sheikh F., Setlur R., Uppal M., et al. Changes in pulmonary compliance following heparin reversal with protamine. Anesth Analg82:SCA96, 1996
2.
DuBois D., DuBois EFA formula to estimate the approximate surface area if height and weight be known. Arch Intern Med17:863,1916
3.
Morris JFSpirometry in the evaluation of pulmonary function. West J Med125: 110, 1976
4.
Baydur A., Behrakis PK, Zin WA, et al. A simple method for assessing the validity of the esophageal balloon technique. Am Rev Respir Dis126:788, 1982
5.
Barnas GM, Mills PJ, Mackenzie CF, et al. Effect of tidal volume on respiratory system resistance and elastance on amplitude and frequency in the normal range of breathing. Am Rev Respir Dis145:522, 1992
6.
Barnas GM, Ho G., Green MD, et al. Effects of analysis method and forcing waveform on measurement of respiratory system mechanics. Respir Physiol89:273, 1992
7.
Barnas GM, Watson RJ, Green MD, et al. Lung and chest wall mechanical properties before and after cardiac surgery with cardiopulmonary bypass. J Appl Physiol76: 166, 1994
8.
Barnas GM, Yoshino K., Loring SH, et al. Impedance and relative displacements of the relaxed chest wall up to 4 Hz. J Appl Physiol62:71, 1987
9.
Barnas GM, Stamenovic D., Lutchen KRLung and chest wall impedances in the dog in normal range of breathing: Effects of pulmonary edema. J Appl Physiol73:1040, 1992
10.
Barnas GM, Mills PJ, Mackenzie CF, et al. Dependences of respiratory system resistance and elastance on amplitude and frequency in the normal range of breathing. Am Rev Respir Dis143:240, 1991
11.
Tuman KJ, McCarthy RJ, March RJ, et al. Morbidity and duration of ICU stay after cardiac surgery: A model for preoperative risk assessment. Chest102: 36, 1992
12.
Anyanwu E., Dittrich H., Gieseking R., et al. Ultrastructural changes in the human lung following cardiopulmonary bypass. Basic Res Cardiol77:309, 1982
13.
Pennock JL, Pierce WS, Waldhausen JAThe management of the lungs during cardiopulmonary bypass. Surg Gynecol Obstet145:917, 1977
14.
Horiguchi T. , Enzan K., Mitsuhata H., et al. Heparin-protamine complexes cause pulmonary hypertension in goats. Anesthesiology83:786, 1995
